The Operating Room Disinfection System segmentation by application delineates five primary clinical domains: orthopedic surgery, cardiac surgery, general surgery, neurosurgery, and other applications. Orthopedic procedures, representing roughly 30 % of installations, drive demand for high‑throughput surface decontamination due to the extensive use of implants and prosthetic components. Cardiac surgery accounts for about 25 % of the market, reflecting stringent sterility requirements for open‑heart operations and the associated higher per‑procedure cost of disinfection equipment. General surgery, with a 20 % share, contributes a broad, volume‑based demand across multiple specialties, emphasizing flexibility and rapid turnaround times. Neurosurgery, comprising 15 % of deployments, necessitates precise, low‑residue disinfection technologies to protect delicate neural tissue and equipment. The residual 10 % classified as other applications includes ophthalmology, ENT, and ambulatory surgical centers, each adding niche but growing demand. Collectively, these application segments define the overall market size, as revenue allocation aligns closely with procedural volume, infection‑risk profile, and capital‑expenditure cycles within each clinical area.